Does AMITRIPTYLINE Cause Product use in unapproved indication? 868 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 868 reports of Product use in unapproved indication have been filed in association with AMITRIPTYLINE (AMITRIPTYLINE HYDROCHLORIDE). This represents 4.3% of all adverse event reports for AMITRIPTYLINE.
868
Reports of Product use in unapproved indication with AMITRIPTYLINE
4.3%
of all AMITRIPTYLINE reports
27
Deaths
229
Hospitalizations
How Dangerous Is Product use in unapproved indication From AMITRIPTYLINE?
Of the 868 reports, 27 (3.1%) resulted in death, 229 (26.4%) required hospitalization, and 83 (9.6%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMITRIPTYLINE. However, 868 reports have been filed with the FAERS database.
What Other Side Effects Does AMITRIPTYLINE Cause?
Toxicity to various agents (3,001)
Drug ineffective (2,344)
Completed suicide (1,678)
Off label use (1,588)
Pain (1,300)
Fall (1,216)
Hypotension (1,205)
Drug abuse (1,116)
Dizziness (1,041)
Constipation (1,035)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which AMITRIPTYLINE Alternatives Have Lower Product use in unapproved indication Risk?
AMITRIPTYLINE vs AMITRIPTYLINE\PERPHENAZINE
AMITRIPTYLINE vs AMIVANTAMAB
AMITRIPTYLINE vs AMIVANTAMAB-VMJW
AMITRIPTYLINE vs AMLODIPINE
AMITRIPTYLINE vs AMLODIPINE BESILATE